At any time, there are more than 300,000 clinical studies happening around the world. The process for bringing new pharmaceuticals to the market is prolonged due to regulation placed on the drugs sector in order to protect public safety. The Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte or BfArM) is the legal narcotics and medical device regulatory authority in Germany. According to the BfArM, “They are involved in the tasks of licensing, improving the safety of medicinal products, detecting and evaluating the risks of medical devices, and monitoring the legal traffic in narcotic drugs and precursors.”

The effects of Brexit are being felt across many different industries in Germany, particularly in the pharma regulatory sector. The BfArM is one of the major licensing authorities in the EU and actively supports the European Medicines Agency in all key areas of drug authorisation and drug safety, together with the Paul Ehrlich institute, more than 480 experts bring their expertise to around 130 scientific bodies of the EMA.

According to Prof. Dr Karl Broich, President of the BfArM, “The organisation makes significant contributions to the supply of patients in Europe with safe medications and will increase these contributions in the years to come after Brexit and the loss of the British licensing authority, the number of authorisation processes will also increase, for Germany in particular.”

Increased demand for regulation following Brexit will likely see substantial growth in the market over the next number of years. At the moment the BfArM employs roughly 1,100 employees across many different specialisms including physicians, pharmacists, chemists, biologists, lawyers, engineers, technical assistants, administrative staff. More than 130 of their nearly 1,100 employees will reach the age of 65 within the next 5 years, in other words, 12 % of the staff will retire in the near future. This will free up numerous jobs that will need to be filled as Europe becomes more reliant on Germany to spearhead regulation following the UK’s exit of the EU.  

EPM Scientific is a global specialist recruitment company working exclusively in the Life Sciences industry. Our expert consultants place talent in the regulatory industry in Germany and across Europe.

Regulatory Jobs

Regulatory Affairs Director
Negotiable, Munich

My Munich based client is looking for an experienced Regulatory Affairs Professional to assist wi...

Apply now
Regulatory Affairs Consultant
Negotiable, Switzerland

Currently partnering with a large client in the Medical Device Industry, we are looking for a Reg...

Apply now
Research Associate - Protein Biochemistry
Up to US$35 per hour, Boston

**Local Candidates to Waltham, MA Preferred** Job opportunity with a top biopharmaceutical compan...

Apply now
Associate Director/Director, Regulatory Affairs CMC
US$150000 - US$185000 per year, United States of America

Title:Associate Director/Director, Regulatory Affairs CMC Salary: $150,000-$185,000 Company Summa...

Apply now
Principal/Sr. Regulatory Affairs Specialist
US$100000 - US$150000 per year, Hayward

Title: Principal/ Sr. Regulatory Affairs Specialist Salary: $100,000-$150,000 Company Summary: A ...

Apply now
Director Regulatory Affairs
US$185000 - US$200000 per year, California

This company is a venture-backed, early-stage biotech company focused on the development of novel...

Apply now
Formulation Development Lead
Negotiable, Region Hannover

Formulation Development Manager Salary: Highly Competitive Location: Hannover, Germany A global l...

Apply now
Sr. Clinical Study Manager
Health, Dental, Vision, 401k, etc., San Diego

Title: Sr. Clinical Study Manager Summary: A clinical stage Bio tech company focusing on immuno-o...

Apply now
Regulatory Submissions Manager - Melbourne & Sydney
Negotiable, Australia

An award-winning global full serviced Clinical Research Organisation with international reputatio...

Apply now